How can we get even better at customizing treatment for our patients and thereby achieve improved outcomes? How do we avoid becoming relegated to mere brokers of psychopharmacologic commodities? A few thoughts in this brief communication.
David J. Scheiderer, MD, MBA, DFAPA
Advertisement
Articles by David J. Scheiderer, MD, MBA, DFAPA
Advertisement
Latest Updated Articles
- PNIPs, SNPs, and Phenotypes
Published: September 12th 2014 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Precision Diagnosis: The New Paradigm for Neurocognitive Disorders
2
The Burning Out of Pharmacists
3
Insomnia in Older Adults: A Holistic Approach
4
Can a Class Action Lawsuit Force Big AI to Make Chatbots Safer?
5
